Table 3.

Spearman’s correlations between SF-36 scores and haematological data in patients with MAC lung disease (n = 235)

	Median (interquartile range)	PF	RP	BP	GH	VT	SF	RE	MH	PCS	MCS	RCS
TP, g/dL	6.9 (6.7–7.3)	−0.11	−0.06	−0.34	−0.13	−0.31	0.06	0.04	−0.02	−0.16	−0.04	0.10
Creatinine, mg/dL	0.66 (0.58–0.76)	0.05	0.10	0.15	0.15	0.17*	0.12	0.08	0.09	0.06	0.18*	0.02
LDH, IU/L	179 (162–199)	−0.16	−0.08	−0.05	−0.05	−0.08	−0.09	−0.04	−0.09	−0.09	−0.04	−0.07
ALP, IU/L	230 (187–289)	−0.25**	−0.21*	−0.12	−0.19**	−0.12	−0.10	−0.19*	−0.11	−0.24**	−0.04	−0.11
KL-6, U/mL	251 (194–393)	−0.22**	−0.26***	−0.09	−0.20*	−0.16	−0.12	−0.19*	−0.10	−0.19*	−0.06	−0.13
WBC, /μL	5600 (4500–6400)	−0.17*	−0.15	0.00	−0.13	−0.07	−0.01	−0.10	−0.002	−0.21**	0.06	−0.04
Haemoglobin, g/dL	13.0 (12.1–13.7)	0.30***	0.23**	0.14	0.18*	0.19*	0.24**	0.23**	0.09	0.22**	0.003	0.20*
Platelets, /μL	21.3 (18.0–24.9)	−0.005	−0.001	0.07	−0.02	0.01	0.01	0.01	0.02	−0.02	0.02	0.03
CRP, mg/dL	0.06 (0.02–0.33)	−0.35***	−0.30***	−0.13	−0.20*	−0.18*	−0.26***	−0.24**	−0.10	−0.28***	0.02	−0.23**
SPD, ng/mL	78 (54–12)	−0.19*	−0.22**	−0.10	−0.03	−0.06	−0.10	−0.17*	−0.06	−0.13	0.03	−0.16
GPL-IgA core, U/mL	1.5 (0.5–7.2)	−0.10	−0.13	−0.10	−0.11	−0.19*	−0.12	−0.14	−0.13	−0.04	−0.13	−0.10

SF-36 36-item short form healthy survey, MAC Mycobacterium avium complex, PF physical functioning, RP role physical, BP bodily pain, GH general health, VT vitality, SF social functioning, RE role-emotional, MH mental health, PCS physical component summary, MCS mental component summary, RCS role/social component summary, TP total protein, LDH lactate dehydrogenase, ALP alkaline phosphatase, KL-6 sialylated carbohydrate antigen KL-6, WBC white blood cell, CRP C-reactive protein, SPD surfactant protein d, GPL-IgA core glycopeptidolipid core immunoglobulin A antibody

*P < 0.01, **P < 0.001, ***P < 0.0001